RxDoctor Payments DataLook up a doctor →

Sarbjit Saini, MD

Allergy · Baltimore, MDNPI 1942235148

Payments from drug & device makers

$2,128,642in general payments, 2019–2025

Across 236 payments — averaging $9019.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1.1M
  • Regeneron$567K
  • Sanofi US Services Inc.$241K
  • Amgen$77K
  • Sanofi$70K
  • Eli Lilly$37K
  • plus $85K from 11 others
$42,668in research payments, 2019–2025

Across 44 payments — averaging $969.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi$12K
  • Novartis$10K
  • Novartis Pharma AG$7K
  • F. Hoffmann-la Roche AG$6K
  • Eli Lilly$5K
  • Regeneron$3K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,128,642 in reported general payments places this provider in the 90th percentile of 29 allergy providers in Maryland.

See all allergy providers in Maryland

Medicare billing

Part B allowed, 2024
$10,461
Medicare patients
48
Services billed
116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →